English | Español
Press release submission | Jan 12, 2022

Efficacy Expectations for Refractory Migraine Patients are Vital for Strong Uptake of Impel's Trudhesa, Spherix Reports

Press release submission | Jan 7, 2022

New Survey From Bausch + Lomb and Glaucoma Research Foundation Reveals Emotional and Social Impact of Hyperemia on Glaucoma Patients

Press release submission | Jan 7, 2022

100% Recovery-GoldenBiotech Announces Topline Results from Unblinded COVID-19 Trial for Oral New Drug Antroquinonol in Hospitalized Mild, Moderate and Severe Patients

Press release submission | Jan 6, 2022

Sutro Biopharma Announces Interim Data from Dose-Expansion Cohort of STRO-002 Phase 1 Study for Patients with Advanced Ovarian Cancer

Press release submission | Jan 5, 2022

NRx Pharmaceuticals Submits Emergency Use Authorization Application to US Food and Drug Administration for ZYESAMI® (aviptadil) to Treat Patients at Immediate Risk of Death from COVID-19 Despite Treatment with Remdesivir and Other Approved Therapies

Bree Gonzales | Jan 5, 2022

Biden: 'We’re mobilizing an additional 1,000 military doctors and nurses to help staff hospitals'
Bree Gonzales | Jan 4, 2022

The No Surprises Act took effect Jan. 1: 'Its effect will eventually be felt by literally everybody'
Press release submission | Jan 4, 2022

Depression screening improves care for patients with cancer

Trending
Patient Daily | Oct 23, 2025

Dallas Breathe Free ENT Specialist: Humidity 'tends to help' with sinus issues
Patient Daily | Oct 23, 2025

Capitol Breathe Free Otolaryngologist: ‘Allergy exacerbations are a common trigger for sinus infections'
+ Pharmaceuticals
Patient Daily | Oct 23, 2025

Empower seeks dismissal of Eli Lilly suit in Texas federal court
+ Pharmaceuticals
Patient Daily | Oct 29, 2025

Paragon Health Institute senior fellow: 340B program 'needs real reform'